Johnson & Johnson Innovation
As Head of JLABS, San Francisco Bay Area, Jeff is responsible for setting the strategy and overseeing all operational activities of JLABS in the Bay Area—including JLABS @ SSF and JLABS @ MBC BioLabs. Jeff joined JLABS in June 2019 from Johnson & Johnson Innovation, California Innovation Center, which he helped to establish and where he led the New Ventures team since 2014. Having joined Johnson & Johnson in 2011, he has also served as a principal making biopharma investments for Johnson & Johnson Development Corporation.
Jeff began his business career as a management consultant at McKinsey & Company. He later served as a healthcare research analyst at JP Morgan Hambrecht & Quist. As an entrepreneur, he ran corporate development and operations for WIDCOMM, a technology company. Later, he served as Chief Financial Officer and Chief Business Officer for Vela Pharmaceuticals, a venture-backed neuroscience drug development company. From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management. He has served as a board director or board observer for over a dozen companies.
Education, Personal, and Fellowship
Jeff graduated Phi Beta Kappa in Biology from Harvard College and earned an MD from Harvard Medical School, where he was a Rotary International Ambassadorial Scholar. He completed his medical-psychiatric internship and psychiatry residency at UCLA's Neuropsychiatric Institute and served as program chief resident. Afterwards, he was awarded and completed a clinical neuropharmacology fellowship, focusing on the care of treatment-refractory patients. He is conversational in six languages.
A member of Class 11, Jeff served his fellowship at Scale Venture Partners under the mentorship of Lou Bock.